◀ Back to FGFR3

DRD1 — FGFR3

Text-mined interactions from Literome

Tzavara et al., Mol Psychiatry 2006 : The marked increase of cortical ACh induced by atomoxetine was dependent upon norepinephrine alpha-1 and/or dopamine D1 receptor activation
Yano et al., Br J Pharmacol 2009 : Galantamine improves apomorphine induced PPI deficits by stimulating mAChRs through increasing brain ACh levels via a dopamine D(1) receptor dependent mechanism and AChE inhibition
Ramírez et al., Brain Res 1997 : Among the 5-HT agents studied, only the 5-HT2A receptor antagonists ketanserin and ritanserin were able to reduce the ACh release induced by dopamine D1 receptor stimulation